Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3K Sell
410
-156
-28% -$3.44K ﹤0.01% 2895
2026
Q1
$8.28K Buy
566
+404
+249% +$5.93K ﹤0.01% 2836
2025
Q4
$2.05K Buy
162
+86
+113% +$1.27K ﹤0.01% 3124
2025
Q3
$1.17K Buy
76
+12
+19% +$193 ﹤0.01% 3184
2025
Q2
$1.01K Sell
64
-128
-67% -$1.94K ﹤0.01% 3191
2025
Q1
$3.67K Buy
192
+124
+182% +$2.71K ﹤0.01% 2785
2024
Q4
$1.62K Sell
68
-25
-27% -$698 ﹤0.01% 3024
2024
Q3
$2.6K Buy
93
+40
+75% +$1.13K ﹤0.01% 2816
2024
Q2
$1.39K Buy
53
+27
+104% +$562 ﹤0.01% 2888
2024
Q1
$569 Hold
26
﹤0.01% 3034
2023
Q4
$605 Buy
26
+5
+24% +$101 ﹤0.01% 3029
2023
Q3
$414 Sell
21
-32
-60% -$630 ﹤0.01% 3139
2023
Q2
$1.2K Sell
53
-27
-34% -$544 ﹤0.01% 2883
2023
Q1
$1.57K Sell
80
-17
-18% -$326 ﹤0.01% 2838
2022
Q4
$1.67K Buy
+97
New +$1.72K ﹤0.01% 2750

Other funds holding RXO

Parallel Advisors's RXO Position: Q2 2026 in Review

Parallel Advisors reduced its RXO (RXO) stake by 28% in Q2 2026, selling an estimated $3.44K and leaving 410 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2895.

Parallel Advisors first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Parallel Advisors held 410 shares of RXO worth $11.3K as of Q2 2026.
  • Parallel Advisors sold 156 RXO shares in Q2 2026, an estimated $3.44K.
  • RXO made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2895 holding.
  • Parallel Advisors first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.